SUVRETTA CAPITAL MANAGEMENT, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$20,416,415
-25.4%
5,883,6930.0%1.10%
-24.6%
Q2 2023$27,359,172
+4.1%
5,883,693
+3.4%
1.46%
+31.8%
Q1 2023$26,283,577
-41.5%
5,689,086
+2.2%
1.11%
-41.2%
Q4 2022$44,966,000
+61.4%
5,565,099
+10.9%
1.89%
+63.3%
Q3 2022$27,861,000
+15.1%
5,020,000
+8.1%
1.16%
+25.8%
Q2 2022$24,200,000
-21.1%
4,645,000
+24.5%
0.92%
-1.8%
Q1 2022$30,680,000
-15.4%
3,732,400
+53.1%
0.94%
+33.5%
Q4 2021$36,274,000
-14.0%
2,437,795
+9.1%
0.70%
-1.3%
Q3 2021$42,194,000
+32.3%
2,233,695
+30.2%
0.71%
+49.1%
Q2 2021$31,889,000
+9.0%
1,715,381
+33.5%
0.48%
+10.2%
Q1 2021$29,246,000
+30.1%
1,284,976
+24.1%
0.43%
+34.9%
Q4 2020$22,479,000
+91.1%
1,035,409
-11.5%
0.32%
+51.4%
Q3 2020$11,760,000
+67.9%
1,170,166
+29.6%
0.21%
+40.4%
Q2 2020$7,006,000
+748.2%
902,800
+1014.6%
0.15%
+586.4%
Q1 2020$826,00081,0000.02%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$13,773,0003.47%
AJU IB Investment Co., Ltd. 175,000$1,439,0002.22%
Frazier Life Sciences Management, L.P. 1,776,479$14,603,0001.24%
First Light Asset Management, LLC 1,672,497$13,748,0001.21%
BVF INC/IL 3,447,946$28,342,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,732,400$30,680,0000.94%
Endurant Capital Management LP 296,508$2,437,0000.64%
Parkman Healthcare Partners LLC 199,846$1,643,0000.48%
Eventide Asset Management 2,708,975$22,268,0000.35%
Lombard Odier Asset Management (Switzerland) SA 391,024$3,214,0000.25%
View complete list of SUTRO BIOPHARMA INC shareholders